594 Participants Needed

SPA-LTC Program for Frailty Syndrome

Recruiting at 3 trial locations
ED
SK
SS
Overseen BySally Shaw
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: McMaster University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This study will evaluate the implementation of the Strengthening a Palliative Approach in Long-Term Care (SPA-LTC) program using a cross-jurisdictional, effectiveness-implementation type II hybrid design (dual testing of clinical and implementation interventions) to assess the implementation (feasibility, fidelity, reach, sustainability) and effectiveness (family satisfaction, staff knowledge and confidence implementing a palliative approach to care, hospital use).

Research Team

SK

Sharon Kaasalainen, PhD

Principal Investigator

McMaster University, School of Nursing

Eligibility Criteria

This trial is for English-speaking residents in long-term care who are quite frail, with a score of 50% or less on the Palliative Performance Scale. It's not suitable for those who aren't fluent in English or are less frail (score above 50%).

Inclusion Criteria

English-speaking LTC residents with a score of 50% or less on the Palliative Performance Scale

Exclusion Criteria

Non-English speaking LTC residents
Residents with a score of more than 50% on the Palliative Performance Scale.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Implementation of the SPA-LTC program in long-term care homes across three provinces

up to 160 weeks
Weekly checklists completed

Follow-up

Participants are monitored for family satisfaction, staff knowledge, and hospital use after the intervention

1-2 months

Post-Bereavement Follow-Up

Follow-up with families and staff after bereavement

6 weeks to 2 months after resident's death

Treatment Details

Interventions

  • Strengthening a Palliative Approach in Long-Term Care (SPA-LTC) Program
Trial Overview The study tests the SPA-LTC program, which aims to improve palliative care in long-term facilities. It looks at how well it works and how feasible it is across different places by measuring family satisfaction and staff knowledge.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Within the intervention arm 9 long-term care homes will receive the SPA-LTC program:3 in Ontario; 3 in Saskatchewan and 3 in Manitoba.
Group II: ControlActive Control1 Intervention
Within the control arm 9 long-term care homes will receive the standard of care: 3 in Ontario; 3 in Saskatchewan and 3 in Manitoba.

Find a Clinic Near You

Who Is Running the Clinical Trial?

McMaster University

Lead Sponsor

Trials
936
Recruited
2,630,000+

Canadian Hospice Palliative Care Association

Collaborator

Trials
1
Recruited
590+

Saskatchewan Health Authority - Regina Area

Collaborator

Trials
29
Recruited
5,400+

Hospice Palliative Care Ontario

Collaborator

Trials
1
Recruited
590+

Canadian Virtual Hospice

Collaborator

Trials
2
Recruited
610+

Interlake-Eastern Regional Health Authority

Collaborator

Trials
1
Recruited
590+

Alberta Health services

Collaborator

Trials
168
Recruited
658,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security